Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen A-M, Elgue G, Funke L, et al. STEM CELLS. 2012;30:1565?74.
Category archives: Abstract international humain
25 – A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions.
Centeno CJ, Al-Sayegh H, Freeman MD, Smith J, Murrell WD, Bubnov R. International Orthopaedics. 2016;40:1755? 65.
23 – Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.
Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. PLoS ONE. 2012;7:e47559.
18 – Pro-Inflammatory Cytokines, IFN and TNF, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially.
Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. PLOS ONE. 2010.
17 – Immunogenicity of Adult Mesenchymal Stem Cells: Lessons from the Fetal Allograft.
Barry FP, Murphy JM, English K, Mahon BP. Stem Cells and Development. 2005.
16 – Interaction of Human Mesenchymal Stem Cells With Cells Involved in Alloantigen-Specific Immune Response Favors the Differentiation of CD4+ T-cell Subsets Expressing a regulatory/suppressive Phenotype.
Rita Maccario, Marina Podestà, Antonia Moretta, Angela Cometa, Patrizia Comoli, Daniela Montagna, Liane Daudt, Adalberto Ibatici, Giovanna Piaggio, Sarah Pozzi, Francesco Frassoni, Franco Locatelli. Haematologica. Avril 2005.
15 – Hypoxia-enhanced Wound-Healing Function of Adipose-Derived Stem Cells: Increase in Stem Cell Proliferation and Up-Regulation of VEGF and bFGF.
Eun Young Lee, Ying Xia, Won-Serk Kim, Myoung Hee Kim, Tae Hwan Kim, Kea Jeung Kim, Byung-Soon Park, Jong-Hyuk Sung. Wound Repair Regen. Juil-août 2009.